Latest Shareholder Support News

Forrestania Resources secured near-unanimous shareholder approval for its acquisition of the Edna May Project and a $310 million capital raising, clearing the path to expand its gold footprint in Western Australia.

Bio-Gene Technology narrowed its loss to $2.33 million in FY26 while progressing key toxicity studies for Flavocide and securing a commercial foothold for Qcide in Japan. The company bolstered its balance sheet with a $3.275 million capital raise to fund ongoing development and production scale-up.

WAM Alternative Assets nearly doubled its pre-tax profit in FY2026, driven by a 9.1% portfolio gain and a decisive shareholder vote backing its strategy. The company declared a 6.0 cents per share dividend, partially franked at 60%, reflecting portfolio maturation and diversification.

Saturn Metals has significantly oversubscribed its Share Purchase Plan, raising $21.28 million against a $5 million target. Combined with a recent $100 million placement, the company now has $121.28 million to accelerate development of its Apollo Hill Gold Project in Western Australia.

Mayfield Childcare has completed a fully subscribed entitlement offer, raising approximately $3 million to support its ongoing operational turnaround.

Stakk is on the cusp of completing its US$63 million acquisition of ParaScript, having secured shareholder approval and completed a A$27 million placement. The combined entity is poised to meet or exceed FY2027 revenue and EBITDA targets, reinforcing its digital trust platform strategy.

Big River Industries (ASX:BRI) reversed a $14.8 million loss in FY25 to a $4.9 million profit in FY26, driven by margin expansion and the acquisition of Johns Building Supplies. The group targets double-digit EBITDA growth in FY27 amid mixed market conditions.

SQX Resources launches a fully underwritten $2.47 million rights issue at a 31% discount to fund accelerated exploration across key US and Australian projects.

Turners Automotive Group delivered record FY26 results with a 14% dividend rise, underpinned by strong growth in Auto Retail, Finance, and Insurance despite geopolitical headwinds.

Kincora Copper has accelerated exploration activities across its Australian portfolio, including partner-funded drilling with AngloGold Ashanti and sole-funded programs at Condobolin, while divesting its Mongolian assets for US$10 million to sharpen focus and strengthen its balance sheet.

Austral Resources has locked in a binding agreement to acquire Hammer Metals, offering a 70.6% premium and creating a stronger Queensland copper entity with significant resource and exploration potential.

Starpharma has successfully completed a $32 million entitlement offer, nearly fully subscribed, to fund its DEP® HER2-Lutetium Phase 1 trial and further develop its oncology pipeline.